IL7 and neoplasm: Because the aim of this study is to investigate whether the addition of an immune biomarker could be used to improve early cancer detection, in Fig. 9b(ii), (iii) we graph tumour size versus the two biomarkers (IL-7 and CA-125), together with the tumour diameters at the detection times.